Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Free Resource Kit


The NAABT Resource Kits are now available. Along with pertinent hardcopy literature, included is a CD (CD not available - pending revisions) which contains many of the files on our Literature Page, plus over 300 other files.

*Resource kit comes in a Privacy Envelope, with "PO Box 333, Farmington, CT 06034" as the return address, no company name on the envelope.

You can order your free Resource Kit by providing your mailing information below. Also you can sign up to receive our buprenorphine treatment newsletter.

Please check here if you would like to be kept informed about buprenorphine through our e-newsletter by adding your email address to our mailing list.

E-mail Address 

If at any time you wish to unsubscribe, please send an email to unsubscribe@naabt.org

The information you provide below will only be used to fill this order, and not for any other purpose. You are invited to review our Terms and Privacy Policy online at http://www.naabt.org/global_privacy.cfm

To order your free Resource Kit on opioid addiction and buprenorphine treatment, please fill out the information below.

Resource kit contents*Items with an asterisk are required.

First Name*
Last Name*
Address*
Address 2
City*
State*
Zip Code*

Where did you hear about the Resource Kit?


    

This page was last modified on : 10/24/2009
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.